Bulgarian 
Croatian
Czech 
Danish
Dutch
Estonian
Finnish
French
German
Greek
Hungarian
Icelandic
Italian
Latvian
Lithuanian
Maltese
Norwegian
Polish
Portuguese 
Romanian
Slovak
Slovenian
Spanish
SwedishArticle Contents
- 1. NAME OF THE MEDICINAL PRODUCT
- 2. STATEMENT OF ACTIVE SUBSTANCE(S)
- 3. LIST OF EXCIPIENTS
- 4. PHARMACEUTICAL FORM AND CONTENTS
- 5. METHOD AND ROUTE(S) OF ADMINISTRATION
- 6. SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN
- 7. OTHER SPECIAL WARNING(S), IF NECESSARY
- 8. EXPIRY DATE
- 9. SPECIAL STORAGE CONDITIONS
- 10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE
- 11. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
- 12. MARKETING AUTHORISATION NUMBERS
- 13. BATCH NUMBER
- 14. GENERAL CLASSIFICATION FOR SUPPLY
- 15. INSTRUCTIONS ON USE
- 16. INFORMATION IN BRAILLE
- 17. UNIQUE IDENTIFIER – 2D BARCODE
- 18. UNIQUE IDENTIFIER - HUMAN READABLE DATA
- 2. METHOD OF ADMINISTRATION
- 3. EXPIRY DATE
- 4. BATCH NUMBER
- 5. CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT
- 6. OTHER
PARTICULARS TO APPEAR ON THE OUTER PACKAGING
OUTER CARTON
1.NAME OF THE MEDICINAL PRODUCT
SANCUSO 3.1 mg/24 hours transdermal patch Granisetron
2.STATEMENT OF ACTIVE SUBSTANCE(S)
Each 52 cm2 transdermal patch contains 34.3 mg of granisetron, releasing 3.1 mg of granisetron per
24hours.
3.LIST OF EXCIPIENTS
Other ingredients:
4.PHARMACEUTICAL FORM AND CONTENTS
1 transdermal patch
5.METHOD AND ROUTE(S) OF ADMINISTRATION
Read the package leaflet before use.
Transdermal use.
6.SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN
Keep out of the sight and reach of children.
7.OTHER SPECIAL WARNING(S), IF NECESSARY
8.EXPIRY DATE
EXP
9.SPECIAL STORAGE CONDITIONS
Store in the original package in order to protect from light.
10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE
11.NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Kyowa Kirin Ltd, Galabank Business Park, Galashiels, TD1 1QH, United Kingdom.
12.MARKETING AUTHORISATION NUMBERS
EU/1/12/766/001
13.BATCH NUMBER
- Moventig - Kyowa Kirin Limited
Prescription drugs listed. Manufacturer: "Kyowa Kirin Limited"
Lot
14.GENERAL CLASSIFICATION FOR SUPPLY
15.INSTRUCTIONS ON USE
16.INFORMATION IN BRAILLE
Sancuso
17.UNIQUE IDENTIFIER – 2D BARCODE
2D barcode carrying the unique identifier included.
18.UNIQUE IDENTIFIER - HUMAN READABLE DATA
PC:
SN:
NN:
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS
SACHET
1. NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION
SANCUSO 3.1 mg/24 h transdermal patch Granisetron
Transdermal use
2.METHOD OF ADMINISTRATION
Read the package leaflet before use.
3.EXPIRY DATE
EXP
4.BATCH NUMBER
Lot
5.CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT
1 transdermal patch
6.OTHER
Store in the original package in order to protect from light.
- Pecfent
- Jalra
- Epivir
- Insuman
- Atazanavir mylan
- Actraphane
Prescription drugs listed:
Keep out of the sight and reach of children.
Kyowa Kirin Ltd
Comments
